| The emerging roles of the polycistronic miR-106b∼ 25 cluster in cancer–A comprehensive review D Mehlich, F Garbicz, PK Włodarski Biomedicine & Pharmacotherapy 107, 1183-1195, 2018 | 46 | 2018 |
| Increased expression of the microRNA 106b~ 25 cluster and its host gene MCM7 in corticotroph pituitary adenomas is associated with tumor invasion and Crooke’s cell morphology F Garbicz, D Mehlich, B Rak, E Sajjad, M Maksymowicz, W Paskal, ... Pituitary 20, 450-463, 2017 | 40 | 2017 |
| Lineage-dependent role of miR-410-3p as oncomiR in gonadotroph and corticotroph pituitary adenomas or tumor suppressor miR in somatotroph adenomas via MAPK, PTEN/AKT, and STAT3 … TM Grzywa, K Klicka, B Rak, D Mehlich, F Garbicz, G Zieliński, ... Endocrine 65, 646-655, 2019 | 32 | 2019 |
| Post-transcriptional regulation of MMP16 and TIMP2 expression via miR-382, miR-410 and miR-200b in endometrial cancer B Rak, D Mehlich, F Garbicz, Z Domosud, W Paskal, JM Marczewska, ... Cancer Genomics & Proteomics 14 (5), 389-401, 2017 | 27 | 2017 |
| Inhibition of PIM kinases in DLBCL targets MYC transcriptional program and augments the efficacy of anti-CD20 antibodies M Szydłowski, F Garbicz, E Jabłońska, P Górniak, D Komar, B Pyrzyńska, ... Cancer Research 81 (23), 6029-6043, 2021 | 23 | 2021 |
| miR-96-5p, miR-134-5p, miR-181b-5p and miR-200b-3p heterogenous expression in sites of prostate cancer versus benign prostate hyperplasia—Archival samples study K Pełka, K Klicka, TM Grzywa, A Gondek, JM Marczewska, F Garbicz, ... Histochemistry and Cell Biology 155 (3), 423-433, 2021 | 19 | 2021 |
| TIMP4 expression is regulated by miR‐200b‐3p in prostate cancer cells M Janiak, W Paskal, B Rak, F Garbicz, R Jarema, K Sikora, P Włodarski Apmis 125 (2), 101-105, 2017 | 19 | 2017 |
| A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer H Tanton, T Sewastianik, HS Seo, D Remillard, RS Pierre, P Bala, ... Science Advances 8 (17), eabm3108, 2022 | 11 | 2022 |
| Epithelial cells of deep infiltrating endometriosis harbor mutations in cancer driver genes A Koppolu, RB Maksym, W Paskal, M Machnicki, B Rak, M Pępek, ... Cells 10 (4), 749, 2021 | 10 | 2021 |
| The expression of MMP-14 and microRNA-410 in FFPE tissues of human endometrial adenocarcinoma B Rak, F Garbicz, W Paskal, K Pełka, JM Marczewska, D Wołosz, ... Universidad de Murcia. Departamento de Biología Celular e Histología, 2016 | 9 | 2016 |
| Multi-omics analyses of early liver injury reveals cell-type-specific transcriptional and epigenomic shift M Migdał, E Tralle, KA Nahia, Ł Bugajski, KZ Kędzierska, F Garbicz, ... BMC genomics 22, 1-15, 2021 | 7 | 2021 |
| The CRBN, CUL4A and DDB1 expression predicts the response to immunomodulatory drugs and survival of multiple myeloma patients J Barankiewicz, A Szumera-Ciećkiewicz, A Salomon-Perzyński, ... Journal of Clinical Medicine 10 (12), 2683, 2021 | 4 | 2021 |
| Intraparenchymal mesenchymal chondrosarcoma of the frontal lobe--a case report and molecular detection of specific gene fusions from archival FFPE sample EA Sajjad, K Sikora, T Paciejewski, F Garbicz, W Paskal, M Szacht, ... Clin Neuropathol 34 (5), 288-93, 2015 | 4 | 2015 |
| Targeting arginase-1 exerts antitumor effects in multiple myeloma and mitigates bortezomib-induced cardiotoxicity K Ramji, TM Grzywa, A Sosnowska, A Paterek, M Okninska, Z Pilch, ... Scientific Reports 12 (1), 19660, 2022 | 2 | 2022 |
| PIM Kinase Inhibition Decreases the Proangiogenic Properties of Multiple Myeloma Cells and Affects the Metabolic State of the Vascular Endothelium F Garbicz, A Szumera-Ciećkiewicz, J Barankiewicz, D Komar, M Pawlak, ... Blood 136, 16-17, 2020 | 1 | 2020 |
| Hodgkin Lymphoma Reed-Sternberg Cells Induce Immunosuppressive and Pro-Angiogenic Phenotype of Tumor-Associated Macrophages in a Paracrine Manner M Szydlowski, M Pawlak, F Garbicz, P Górniak, J Żurańska, M Król, ... Blood 136, 30, 2020 | 1 | 2020 |
| CDK12/13: A Promising New Therapeutic Target in ALL J Dudkiewicz, F Garbicz, PK Wlodarski Blood 142, 2266, 2023 | | 2023 |
| PIM1 Point Mutations Increase Migration of Diffuse Large B-Cell Lymphoma (DLBCL) Cells A Zolyniak, D Komar, S Debek, F Garbicz, M Pawlak, P Juszczyński Blood 142, 2772, 2023 | | 2023 |
| Epigenetic and Transcriptional Consequences of PIM Kinase Activity and Inhibition in Diffuse Large B-Cell Lymphoma (DLBCL) S Debek, D Komar, F Garbicz, A Zolyniak, M Pawlak, E Jablonska, ... Blood 142, 5713, 2023 | | 2023 |
| Transcriptomic Features Influencing Anti-Myeloma Drug Resistance in Human Multiple Myeloma Cell Lines F Garbicz, I Misiewicz-Krzeminska, RD Carrasco, P Juszczyński Blood 142, 1943, 2023 | | 2023 |
Dawid MehlichPolish Academy of ScienceVerified email at imol.institute
